Advertisement
Advertisement
Trending on AJMC
1
Occupational Triggers Fuel Half of CHE Cases, Spanish Study Finds
2
Brexpiprazole and Dextromethorphan-Bupropion: Mechanisms of Action and Key Clinical Trial Data for Approved Alzheimer's Disease Agitation Therapies
3
Readable Consent Forms Could Boost Trial Enrollment: Oyepeju Abioye-Akintola, MD, MSc
4
Closing the Recognition Gap: Underdiagnosis, Patient Education, and Treatment Goals in Alzheimer's Disease Agitation
5